Trials / Conditions / Neurotoxicity Syndromes
Neurotoxicity Syndromes
7 registered clinical trials studyying Neurotoxicity Syndromes — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812 | Beth Israel Deaconess Medical Center | N/A |
| Not Yet Recruiting | Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy NCT07095998 | Ka-Wai Ho | N/A |
| Completed | A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity NCT04150913 | Marcela V. Maus, M.D.,Ph.D. | Phase 2 |
| Terminated | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Ne NCT03954106 | Jazz Pharmaceuticals | Phase 2 |
| Active Not Recruiting | To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity NCT02481336 | National Cheng-Kung University Hospital | — |
| Withdrawn | Scopolamine Treatment for Patients With Organophosphate Poisoning NCT00389259 | Assaf-Harofeh Medical Center | N/A |
| Terminated | A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity NCT00176553 | University of Medicine and Dentistry of New Jersey | N/A |